NovaBay Pharmaceuticals, Inc. Operating Income

Operating Income of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Income growth rates and interactive chart. Operating income is the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation, and cost of goods sold (COGS). Operating income–also called income from operations–takes a company's gross income, which is equivalent to total revenue minus COGS, and subtracts all operating expenses. A business's operating expenses are costs incurred from normal operating activities and include items such as office supplies and utilities. Operating income is measured before interest and tax expenses and is a good gauge of a company's operational profitability.


Highlights and Quick Summary

  • Operating Income for the quarter ending September 30, 2022 was $-457 Thousand (a -78.76% decrease compared to previous quarter)
  • Year-over-year quarterly Operating Income decreased by -85.69%
  • Annual Operating Income for 2021 was $-8.86 Million (a 37.91% increase from previous year)
  • Annual Operating Income for 2020 was $-6.43 Million (a -31.64% decrease from previous year)
  • Annual Operating Income for 2019 was $-9.4 Million (a 19.43% increase from previous year)
  • Twelve month Operating Income ending September 30, 2022 was $-8.19 Million (a -18.29% decrease compared to previous quarter)
  • Twelve month trailing Operating Income decreased by -7.64% year-over-year
Trailing Operating Income for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$-8.19 Million $-10 Million $-9.72 Million $-8.86 Million
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Income of NovaBay Pharmaceuticals, Inc.

Most recent Operating Incomeof NBY including historical data for past 10 years.

Interactive Chart of Operating Income of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Operating Income for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-0.46 $-2.15 $-2.38
2021 $-3.19 $-2.29 $-1.86 $-1.52 $-8.86
2020 $-1.76 $-2.06 $-1.07 $-1.54 $-6.43
2019 $-2.24 $-1.71 $-1.38 $-4.07 $-9.4
2018 $-1.61 $-1.81 $-2.08 $-2.37 $-7.87
2017 $0.39 $-2.17 $-1.76 $-3.78 $-7.31
2016 $-2.03 $-2.06 $-2.24 $-4.65 $-10.98
2015 $-6.27 $-5.35 $-4.86 $-4.66 $-21.14
2014 $-4.91 $-4.11 $-3.79 $-4.1 $-16.9
2013 $-4.87 $-2.98 $-4.15 $-3.49 $-15.49
2012 $-2.84 $-0.11 $-2.88 $-2.49 $-8.31
2011 $-2.47 $-4.32

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology